Zhanna Golodryga
appointed Zhanna Golodryga to the Board, effective as of April 1, 2025
Highest-materiality recent filing
AGCO Q1 net sales up 14.3% to $2.3B; adjusted EPS $0.94 vs $0.41; raises FY26 EPS outlook to ~$6.00
Net sales $2.3B +14.3% YoY; reported EPS $0.76, adjusted EPS $0.94 (vs $0.41 prior year).
AGCO 2025 net sales down 13.5%; Q4 adjusted EPS beats; guides 2026 above 2025
Full year net sales $10.1B, down 13.5%; reported EPS $9.75 includes gain on TAFE sale.
AGCO Q3 adj EPS $1.35 vs $0.68 YoY; raises FY adj EPS outlook to ~$5.00
Net sales $2.5B, down 4.7% YoY; ex-currency and divestitures, down 8.4%.
AGCO completes sale of TAFE interest for $260M, after-tax proceeds ~$230M
Completed sale of ownership interest in TAFE to TAFE for $260 million aggregate consideration.
AGCO Q2 net sales down 18.8% to $2.6B; adjusted EPS $1.35 vs $2.53 a year ago
Reported EPS of $4.22 includes items from G&P divestiture; adjusted EPS $1.35.
AGCO announces $1B share repurchase program after TAFE resolution
Board authorized up to $1 billion of common stock repurchases.
TAFE will repurchase AGCO's remaining shareholdings in TAFE for an aggregate $260 million.
Net sales $2.1B, down 30.0% YoY; reported EPS $0.14 vs $2.25 prior year.
AGCO 2024 adjusted EPS $7.50, sales down 19.1%; guides 2025 EPS $4.00-$4.50
Net sales $11.7B in 2024, down 19.1% YoY; reported EPS $(5.69) (includes impairment, restructuring, loss on Grain & Protein sale).
AGCO targets 14-15% op margin by 2029; 2025 outlook: sales ~$9.6B, EPS $4-$4.50
By 2029, targets: adjusted operating margins 14%-15%, outgrow industry by 4-5% annually, FCF conversion 75-100%.
AGCO Q3 net sales fall 24.8% to $2.6B, adjusted EPS $0.68; reaffirms 9% margin target
Q3 net sales $2.6B, down 24.8% YoY; reported EPS $0.40 vs $3.74; adjusted EPS $0.68 vs $3.97.
AGCO completes $700M divestiture of Grain & Protein business to American Industrial Partners
All-cash transaction valued at ~$700M closed November 1, 2024.
AGCO reports Q2 adjusted EPS $2.53 vs $4.29 YoY; lowers 2024 guidance to ~$8.00
Net sales $3.2B, down 15.1% YoY; reported EPS $(4.92) includes estimated loss on Grain & Protein held for sale.
AGCO sells Grain & Protein business to AIP for $700M; expects $450-$475M loss
Purchase price $700M in cash; 8.3x adjusted EBITDA multiple (TTM as of March 31, 2024).
AGCO initiates restructuring; $150-200M termination costs, up to 6% workforce cut
One-time termination benefits of $150M-$200M, mostly cash severance and benefits.
AGCO Q1 EPS falls to $2.25; announces $2.50 special dividend; closes PTx Trimble JV
Net sales $2.9B (-12.1% YoY); reported EPS $2.25, adjusted EPS $2.32 (vs $3.10/$3.51 Q1 2023).
AGCO terminates commercial agreements with TAFE; 2023 purchases were $171.6M
AGCO gave notice to TAFE on April 26, 2024, ending commercial relationships.
appointed Zhanna Golodryga to the Board, effective as of April 1, 2025
succeeding Damon Audia who has served in that role since September 2023. Mr. Audia will continue to serve in his role as Senior Vice President and Chief Financial Officer.
On May 16, 2024, AGCO Corporation (the “Company”) reported that Indira Agarwal was appointed Vice President and Chief Accounting Officer of the Company, effective June 17, 2024 (the “Effective Date”).
Max materiality 0.85 · Median 0.68 · Most common event other_material